A Phase 2a Diabetic Kidney Disease Study
Condition: Diabetic Kidney Disease Interventions: Drug: MEDI3506; Drug: Placebo Sponsor: AstraZeneca Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials